Comerica Bank’s Krystal Biotech KRYS Stock Holding History

Comerica Bank’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$1.4M	Sell	5,692 -1,459	-20%	-$307K	0.01%	1308
2025 Q3	$1.26M	Sell	7,151 -1,557	-18%	-$233K	﹤0.01%	1411
2025 Q2	$1.2M	Buy	8,708 +7	+0.1%	+$1.03K	﹤0.01%	1426
2025 Q1	$1.57M	Sell	8,701 -189	-2%	-$31.8K	0.01%	1251
2024 Q4	$1.39M	Sell	8,890 -207	-2%	-$36.7K	0.01%	1353
2024 Q3	$1.66M	Sell	9,097 -121	-1%	-$23.3K	0.01%	1243
2024 Q2	$1.69M	Buy	9,218 +9,055	+5,555%	+$1.52M	0.01%	1207
2024 Q1	$29K	Sell	163 -41	-20%	-$5.7K	﹤0.01%	2923
2023 Q4	$25.3K	Buy	204 +71	+53%	+$7.87K	﹤0.01%	2913
2023 Q3	$15.5K	Buy	+133	New	+$16.2K	﹤0.01%	3075

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Comerica Bank's KRYS Position: Q4 2025 in Review

Comerica Bank reduced its Krystal Biotech (KRYS) stake by 20% in Q4 2025, selling an estimated $307K and leaving 5,692 shares worth $1.4M. The position accounts for 0.01% of the portfolio, ranked #1308.

Comerica Bank first reported a position in KRYS in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.69M in Q2 2024. 334 funds tracked by Wall St. Rank hold KRYS as of Q4 2025.

Comerica Bank held 5,692 shares of Krystal Biotech worth $1.4M as of Q4 2025.
Comerica Bank sold 1,459 Krystal Biotech shares in Q4 2025, an estimated $307K.
Krystal Biotech made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1308 holding.
Comerica Bank first reported a position in Krystal Biotech in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Krystal Biotech position peaked at $1.69M in Q2 2024.
334 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.